Erlotinib hydrochloride (Form B) contains not less than 98.0 percent and not more than 102.0 percent of C22H23N3O4•HCl, calculated on the anhydrous.

共有 1 個藥物證書使用此成份

"永信"鹽酸厄洛替尼
Erlotinib Hydrochloride "Yung Shin"

• 申請商: 永信藥品工業股份有限公司
• 適應症: 抗腫瘤藥物。
• 發證日期: 2020-03-26